Teza Capital Management LLC acquired a new stake in Clarivate Plc (NYSE:CLVT – Get Rating) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 35,613 shares of the company’s stock, valued at approximately $334,000.
A number of other large investors have also recently added to or reduced their stakes in CLVT. US Bancorp DE lifted its holdings in Clarivate by 5.6% in the first quarter. US Bancorp DE now owns 14,343 shares of the company’s stock valued at $240,000 after acquiring an additional 765 shares during the last quarter. HighTower Advisors LLC lifted its stake in Clarivate by 19.1% during the first quarter. HighTower Advisors LLC now owns 98,518 shares of the company’s stock worth $1,656,000 after purchasing an additional 15,785 shares in the last quarter. Private Advisor Group LLC acquired a new position in Clarivate during the first quarter worth $191,000. AlphaCrest Capital Management LLC lifted its stake in Clarivate by 47.7% during the first quarter. AlphaCrest Capital Management LLC now owns 25,536 shares of the company’s stock worth $428,000 after purchasing an additional 8,243 shares in the last quarter. Finally, Healthcare of Ontario Pension Plan Trust Fund acquired a new position in Clarivate during the first quarter worth $204,000. 87.34% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
A number of research firms have commented on CLVT. Morgan Stanley cut Clarivate from an “overweight” rating to an “equal weight” rating and upped their price target for the stock from $11.00 to $12.00 in a research note on Monday, February 6th. Royal Bank of Canada upped their price target on Clarivate from $12.00 to $14.00 and gave the stock an “outperform” rating in a research note on Thursday, March 2nd. Wells Fargo & Company increased their price objective on Clarivate from $14.00 to $15.00 and gave the company an “overweight” rating in a research note on Thursday, March 2nd. Finally, TheStreet cut Clarivate from a “c-” rating to a “d” rating in a research note on Monday, November 21st. One equities research analyst has rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $13.88.
Clarivate Stock Down 5.4 %
Clarivate Plc engages in the provision of global information, analytics and workflow solutions. It operates through the Science and Intellectual Property segments. The Science segment is composed of the academia and government, and life science and healthcare product lines. The Intellectual Property segment includes the patent, trademark, domain, and IP management product lines.
- Get a free copy of the StockNews.com research report on Clarivate (CLVT)
- Here’s 2 Beaten Down Stocks to Help Your Portfolio Recovery
- What the SVB Financial Collapse Means for U.S. Banks
- MarketBeat Week in Review – 3/6 – 3/10
- 2 Offshore Drilling Stocks Set to Extract Big Profits
- Three Staples Stocks With Double-Digit Upside Ahead
Receive News & Ratings for Clarivate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clarivate and related companies with MarketBeat.com's FREE daily email newsletter.